Recruiting
Adenocarcinoma gastric+2
RecruitingStudy on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer
Registered drugNo placebo
Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer
Registered drugNo placebo
- Disease:Adenocarcinoma gastricOesophageal adenocarcinoma+1
- Substances:[Al[18F]F]Fapi-74Ioxitalamate meglumine
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:[Al[18F]F]Fapi-74
